Biotech · Public company · Bothell, WA, US
Immunome Inc.
Ticker IMNM · SEC CIK 0001472012
Track this companyFree. Adds Immunome Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials105 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline12
- AL102Phase 3 · DesmoidClinicalTrials.gov · fetched Nov 12, 2026
- 177Lu-IM-3050Phase 1 · Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- IM-1021Phase 1 · Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- IM-1617Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- IMM-BCP-01Phase 1 · SARS-CoV2 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Itraconazole (200 mg)Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin 400 mgPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- varegacestatPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Varegacestat Reference FormulationPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Varegacestat Test Formulation APhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Varegacestat Test Formulation BPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Varegacestat Test Formulation CPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced CancerPHASE1 · RECRUITING · started Jun 19, 2026ClinicalTrials.gov NCT07505771 · fetched Nov 12, 2026
- A Phase 1 Study of IM-1617 in Participants With Advanced CancerPHASE1 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07578571 · fetched Nov 12, 2026
- A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy ParticipantsPHASE1 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07610005 · fetched Nov 12, 2026
- A Varegacestat Hepatic Impairment StudyPHASE1 · COMPLETED · started Mar 7, 2025ClinicalTrials.gov NCT06841315 · fetched Nov 12, 2026
- A Phase 1 Study of IM-1021 in Participants With Advanced CancerPHASE1 · RECRUITING · started Feb 26, 2025ClinicalTrials.gov NCT06823167 · fetched Nov 12, 2026
- A Phase 1 Mass Balance Study of VaregacestatPHASE1 · COMPLETED · started Feb 25, 2025ClinicalTrials.gov NCT06845852 · fetched Nov 12, 2026
- A Cardiac Liability Study of Varegacestat in Healthy ParticipantsPHASE1 · COMPLETED · started Feb 24, 2025ClinicalTrials.gov NCT06855264 · fetched Nov 12, 2026
- A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy ParticipantsPHASE1 · COMPLETED · started Nov 11, 2024ClinicalTrials.gov NCT06677996 · fetched Nov 12, 2026
- IMM-BCP-01 in Mild to Moderate COVID-19PHASE1 · TERMINATED · started Jun 3, 2022ClinicalTrials.gov NCT05429021 · fetched Nov 12, 2026
- A Study of AL102 in Patients With Progressing Desmoid TumorsPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 1, 2021ClinicalTrials.gov NCT04871282 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 17, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 15, 2025 · fetched Nov 12, 2026